TrademarkDir
Serial #78435448
DEAD

Serial Number

78435448

Owner

NPS PHARMACEUTICALS, INC.

Attorney

Michael E. Mangelson

Filing Date

Jun 15, 2004

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

Serial #78435448 Trademark

Serial Number: 78435448

Serial #78435448 is a trademark filed by NPS PHARMACEUTICALS, INC. on June 15, 2004. The trademark is classified under Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

NPS PHARMACEUTICALS, INC. (175 trademarks)

550 Hills Drive, 3rd Floor
Bedminster, NJ 07921

Entity Type: 03

Trademark Details

Filing Date

June 15, 2004

Registration Date

Not Registered

Published for Opposition

May 24, 2005

Goods & Services

Drug delivery apparatus, namely, patient triggered injector for the delivery of pharmaceuticals

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Oct 21, 2008 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 21, 2008 ABN6
SOU EXTENSION 5 GRANTED
Mar 18, 2008 EX5G
PAPER RECEIVED
Feb 19, 2008 MAIL
SOU EXTENSION 5 FILED
Feb 14, 2008 EXT5
SOU EXTENSION 4 GRANTED
Aug 15, 2007 EX4G
SOU EXTENSION 4 FILED
Aug 15, 2007 EXT4
PAPER RECEIVED
Aug 15, 2007 MAIL
SOU EXTENSION 3 GRANTED
Mar 24, 2007 EX3G
SOU EXTENSION 3 FILED
Jan 16, 2007 EXT3
PAPER RECEIVED
Jan 16, 2007 MAIL
SOU EXTENSION 2 GRANTED
Sep 7, 2006 EX2G
SOU EXTENSION 2 FILED
Aug 1, 2006 EXT2
PAPER RECEIVED
Aug 1, 2006 MAIL
SOU EXTENSION 1 GRANTED
Feb 18, 2006 EX1G
SOU EXTENSION 1 FILED
Jan 27, 2006 EXT1
PAPER RECEIVED
Jan 27, 2006 MAIL
NOA MAILED - SOU REQUIRED FROM APPLICANT
Aug 16, 2005 NOAM
PUBLISHED FOR OPPOSITION
May 24, 2005 PUBO
NOTICE OF PUBLICATION
May 4, 2005 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 1, 2005 PREV
ASSIGNED TO LIE
Jan 25, 2005 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 18, 2005 CNSA
ASSIGNED TO EXAMINER
Jan 18, 2005 DOCK
NEW APPLICATION ENTERED
Jun 22, 2004 NWAP

Related Trademarks

More from this Owner

PREOTACT

PREOTACT

PREOTACT

PREOTACT

PREOS

PREOS

PREOS

PREOS

RAREVANTAGE

RAREVANTAGE

RAREVANTAGE

RAREVANTAGE